The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Stefan Loren - Perceptive Advisors, LLC - Analyst
: Thank you very much, good afternoon and thanks for taking the call. I was just wondering if you could touch a little bit on the thought behind the
multi-approach you now have going forward to anthrax vis-a-vis Valortim and the RFP at this point. Can those coexist well together? Do you think
it gives you a nice advantage going forward?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
Question: Stefan Loren - Perceptive Advisors, LLC - Analyst
: Thank you. I'll jump back into the queue. I've got one more question.
Question: Christopher Brock - Advanced Equities - Analyst
: I don't know if this is public knowledge or not, but how many other companies have submitted RFPs for the award -- for the anthrax award in, I
think, you said it was May?
Question: Christopher Brock - Advanced Equities - Analyst
: Okay, great. Congratulations on the acquisition.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
Question: Stefan Loren - Perceptive Advisors, LLC - Analyst
: Thank you. Just wanted to follow up on the UK assets that you're getting. Obviously, you're going to be bringing some scientists on board, it sounds
like. But can you give us a little bit more specific on that? And then, comment -- the dollar hasn't been as strong as, I guess, many of us would like
it to be, what is this going to do the burn rate going forward?
|